open access
First-in-human radiofrequency ablation of ventricular tachycardia performed through an Atrial Flow Regulator device
Affiliations- St. Wojciech Hospital COPERNICUS, PL Gdansk, Poland, Długie Ogrody, Gdansk, Poland
- Medical University of Gdansk, Skłodowskiej-Curie 3a, 80-210 Gdansk, Poland
- Department of Cardiology and Angiology, Kashubian Center for Heart and Vascular Diseases, Pomeranian Hospitals, Wejherowo, Poland
open access
Abstract
Abstract
About this articleTitle
First-in-human radiofrequency ablation of ventricular tachycardia performed through an Atrial Flow Regulator device
Journal
Issue
Article type
Technology Note
Pages
161-162
Early publication date
2020-12-01
Published online
2020-12-01
DOI
10.5603/CJ.a2020.0172
Pubmed
Bibliographic record
Cardiol J 2021;28(1):161-162.
Authors
Mateusz Wilkowski
Łukasz Lewicki
Rafał Olszewski
Adam Priebe
Miłosz J. Jaguszewski
Marek Szołkiewicz
References (3)- Muser D, Liang JJ, Santangeli P. Electrical storm in patients with implantable cardioverter-defibrillators: a practical overview. J Innov Card Rhythm Manag. 2017; 8(10): 2853–2861.
- Lewicki Ł, Sabiniewicz R, Siebert J, et al. Atrial flow regulator as a novel therapy for patients with chronic heart failure. Cardiol J. 2020; 27(3): 309–311.
- Paitazoglou C, Özdemir R, Pfister R, et al. The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction. EuroIntervention. 2019; 15(5): 403–410.